Home › Funds › Sofinnova Investments, Inc. › COGT

Sofinnova Investments, Inc. position in COGT

COGENT BIOSCIENCES INC · Health Care

Sofinnova Investments, Inc. reported holding 1,035,148 shares of COGT (COGENT BIOSCIENCES INC) in its Q2 2026 13F filing — a position valued at US$40.1M, representing 2.13% of its reported portfolio and ranking #14 among its reported holdings. Sofinnova Investments, Inc. has disclosed COGT holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)1.04M sh
Reported value held$40.06M
Portfolio Weight2.13%
First reportedQ1 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Sofinnova Investments, Inc.'s COGT position evolved

Sofinnova Investments, Inc. first disclosed a stake in COGT in Q1 2024 at 2,400,771 shares (US$16.1M). The position peaked in Q1 2026 at 2,113,551 shares, worth US$81.4M. Across 10 filings, Sofinnova Investments, Inc. increased the stake 4 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,035,148 shares valued at US$40.1M — a reduction of -1,078,403 shares quarter over quarter.. Notable position changes include a 165% increase in Q1 2025 (shares rose 20% over the following quarter), a 70% trim in Q2 2025 (shares rose 100% over the following quarter), a 222% increase in Q3 2025 (shares rose 147% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 2.40M $16.13M New
Q2 2024 2.77M $23.38M Add
Q3 2024 2.27M $24.46M Reduce
Q4 2024 823.16K $6.42M Reduce
Q1 2025 2.18M $13.07M Add
Q2 2025 660.00K $4.74M Reduce
Q3 2025 2.13M $30.56M Add
Q4 2025 1.97M $70.10M Reduce
Q1 2026 2.11M $81.35M Add
Q2 2026 1.04M $40.06M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About COGT and 13F data

COGT (COGENT BIOSCIENCES INC) is a Health Care company. 59 other funds we track also report a position in COGT — the largest reported positions include Fairmount Funds Management LLC (US$213.0M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$193.7M), TCG Crossover Management, LLC (US$187.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding COGT

All COGT fund holders →

FAQ

How long has Sofinnova Investments, Inc. held COGT?

Sofinnova Investments, Inc. has disclosed COGT holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

What is Sofinnova Investments, Inc.'s current position in COGT?

As of Q2 2026, Sofinnova Investments, Inc. holds 1.04M shares of COGT (COGENT BIOSCIENCES INC), valued at $40.06M, representing 2.13% of its reported portfolio and ranking #14.

Has Sofinnova Investments, Inc. been buying or selling COGT?

In the latest 13F filing (Q2 2026), Sofinnova Investments, Inc. reduced its position in COGT. The position peaked in Q1 2026 at 2.11M shares.

Which other funds hold COGT?

Other major institutional holders of COGT include Fairmount Funds Management LLC, DEERFIELD MANAGEMENT COMPANY, L.P., TCG Crossover Management, LLC, among 59 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.